Back to news

MEDIROM Regains Compliance with Nasdaq’s Periodic Filing Requirement

Globe Newswire•20/11/2026•18:42 ET
4

Key Highlights

  • ➤MEDIROM regained compliance with Nasdaq’s periodic filing requirement.
  • ➤Form 20-F for year ended December 31, 2025 filed November 18, 2026.
  • ➤Nasdaq closed the matter concerning MEDIROM’s delayed annual report filing.
  • ➤Minimum bid price deficiency remains unresolved; compliance deadline is April 5, 2027.

TOKYO, Nov. 20, 2026 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq: MRM) (the “Company”) today announced that it received written notice dated November 20, 2026, from Nasdaq Listing Qualifications confirming that the Company has regained compliance with the periodic filing requirement under Nasdaq Listing Rule 5250(c)(1), because the Company filed its Form 20-F for the year ended December 31, 2025 on November 18, 2026. Accordingly, Nasdaq has closed the matter relating to the delayed filing of the Company’s annual report.

The Company remains subject to the previously disclosed minimum bid price deficiency under Nasdaq Listing Rule 5550(a)(2) and has until April 5, 2027 to regain compliance with that requirement. Nasdaq’s confirmation regarding the periodic filing requirement does not resolve this separate deficiency.

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in